Genetics of osteoporosis from genome-wide association studies: advances and challenges (original) (raw)

• Kanis, J. A. Diagnosis of osteoporosis. Osteoporos. Int. 7 (Suppl. 3), S108–S116 (1997).
  Article PubMed Google Scholar
• Burge, R. et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J. Bone Miner. Res. 22, 465–475 (2007).
  Article PubMed Google Scholar
• Kanis, J. A., Johnell, O., Oden, A., Johansson, H. & McCloskey, E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 19, 385–397 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Slemenda, C. W. et al. The genetics of proximal femur geometry, distribution of bone mass and bone mineral density. Osteoporos. Int. 6, 178–182 (1996).
  Article CAS PubMed Google Scholar
• Smith, D. M., Nance, W. E., Kang, K. W., Christian, J. C. & Johnston, C. C. Jr. Genetic factors in determining bone mass. J. Clin. Invest. 52, 2800–2808 (1973).
  Article CAS PubMed PubMed Central Google Scholar
• Arden, N. K., Baker, J., Hogg, C., Baan, K. & Spector, T. D. The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J. Bone Miner. Res. 11, 530–534 (1996).
  Article CAS PubMed Google Scholar
• Marshall, D., Johnell, O. & Wedel, H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312, 1254–1259 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Jergas, M. & Gluer, C. C. Assessment of fracture risk by bone density measurements. Semin. Nucl. Med. 27, 261–275 (1997).
  Article CAS PubMed Google Scholar
• Andrew, T., Antioniades, L., Scurrah, K. J., Macgregor, A. J. & Spector, T. D. Risk of wrist fracture in women is heritable and is influenced by genes that are largely independent of those influencing BMD. J. Bone Miner. Res. 20, 67–74 (2005).
  Article PubMed Google Scholar
• Michaelsson, K., Melhus, H., Ferm, H., Ahlbom, A. & Pedersen, N. L. Genetic liability to fractures in the elderly. Arch. Intern. Med. 165, 1825–1830 (2005).
  Article PubMed Google Scholar
• Kaufman, J. M. et al. Genome-wide linkage screen of bone mineral density (BMD) in European pedigrees ascertained through a male relative with low BMD values: evidence for quantitative trait loci on 17q21-23, 11q12-13, 13q12-14, and 22q11. J. Clin. Endocrinol. Metab. 93, 3755–3762 (2008).
  Article CAS PubMed Google Scholar
• Hsu, Y. H. et al. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet. 118, 568–577 (2006).
  Article CAS PubMed Google Scholar
• Peacock, M. et al. Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. Bone 45, 443–448 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Xiao, P. et al. Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J. Bone Miner. Res. 21, 1536–1544 (2006).
  Article CAS PubMed Google Scholar
• Ioannidis, J. P. et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J. Bone Miner. Res. 22, 173–183 (2007).
  Article CAS PubMed Google Scholar
• Ralston, S. H. & Uitterlinden, A. G. Genetics of osteoporosis. Endocr. Rev. 31, 629–662 (2010).
  Article CAS PubMed Google Scholar
• Richards, J. B. et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann. Intern. Med. 151, 528–537 (2009).
  Article PubMed PubMed Central Google Scholar
• Ferrari, S. L. et al. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Hum. Genet. 74, 866–875 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• van Meurs, J. B. et al. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA 299, 1277–1290 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Richards, J. B. et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371, 1505–1512 (2008). Together with reference 21, these papers were the first GWASs for osteoporosis, and they made it clear that there were no common genetic variants of large effect for osteoporosis.
  Article CAS PubMed PubMed Central Google Scholar
• Styrkarsdottir, U. et al. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 358, 2355–2365 (2008).
  Article CAS PubMed Google Scholar
• Styrkarsdottir, U. et al. New sequence variants associated with bone mineral density. Nature Genet. 41, 15–17 (2009).
  Article CAS PubMed Google Scholar
• Timpson, N. J. et al. Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Hum. Mol. Genet. 18, 1510–1517 (2009). This is the only GWAS for BMD that has been conducted in children.
  Article CAS PubMed PubMed Central Google Scholar
• Xiong, D. H. et al. Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am. J. Hum. Genet. 84, 388–398 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rivadeneira, F. et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nature Genet. 41, 1199–1206 (2009). This is the first large-scale consortium-style GWAS for osteoporosis. This paper identified many clinically relevant drug targets for osteoporosis and substantially expanded the number of loci associated with BMD.
  Article CAS PubMed Google Scholar
• Estrada, K. et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genet. 44, 491–501 (2012). This is the largest global effort to describe the genetic determinants of BMD and fracture. Using BMD loci, this paper was also the first to assess the contribution of BMD GWAS loci to fracture in a large sample size.
  Article CAS PubMed Google Scholar
• Morris, A. P. Transethnic meta-analysis of genomewide association studies. Genet. Epidemiol. 35, 809–822 (2011).
  Article PubMed PubMed Central Google Scholar
• Dastani, Z. et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 8, e1002607 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Duncan, E. L. et al. Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet. 7, e1001372 (2011). This is an important paper demonstrating the relative use of selecting extremes of a phenotypic continuum to identify common genetic variants.
  Article CAS PubMed PubMed Central Google Scholar
• Hsu, Y. H. et al. An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility loci for osteoporosis-related traits. PLoS Genet. 6, e1000977 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zheng, H. et al. WNT16 influences bone mineral density, cortical bone thickness, bone strength and osteoporotic fracture risk. PLoS Genet. 5 Jul 2012 (doi: 10.1371/journal.pgen.1002745). Together with reference 32, this paper showed that forearm and total body BMD had allelic architectures that appeared to be less polygenic than lumbar spine and femoral neck sites.
  Article CAS PubMed PubMed Central Google Scholar
• Medina-Gomez, C. et al. Meta-analysis of genome-wide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 5 Jul 2012 (doi: 10.1371/journal.pgen.1002718).
  Article CAS PubMed PubMed Central Google Scholar
• Frazer, K. A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
  Article CAS PubMed Google Scholar
• Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era—concepts and misconceptions. Nature Rev. Genet. 9, 255–266 (2008).
  Article CAS PubMed Google Scholar
• Guo, Y. et al. Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet. 6, e1000806 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Cummings, S. R. et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N. Engl. J. Med. 361, 756–765 (2009).
  Article CAS PubMed Google Scholar
• Duncan, E. L. & Brown, M. A. Clinical review 2: genetic determinants of bone density and fracture risk—state of the art and future directions. J. Clin. Endocrinol. Metabolism 95, 2576–2587 (2010).
  Article CAS Google Scholar
• Angers, S. & Moon, R. T. Proximal events in Wnt signal transduction. Nature Rev. Mol. Cell Biol. 10, 468–477 (2009).
  Article CAS Google Scholar
• Kearns, A. E., Khosla, S. & Kostenuik, P. J. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29, 155–192 (2008).
  Article CAS PubMed Google Scholar
• Komori, T. Signaling networks in RUNX2-dependent bone development. J. Cell. Biochem. 112, 750–755 (2011).
  Article CAS PubMed Google Scholar
• Kubota, T., Michigami, T. & Ozono, K. Wnt signaling in bone metabolism. J. Bone Miner. Metabolism 27, 265–271 (2009).
  Article CAS Google Scholar
• Guo, J. et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell. Metabolism 11, 161–171 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Akiyama, H. et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev. 18, 1072–1087 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Gong, Y. et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am. J. Hum. Genet. 59, 146–151 (1996).
  CAS PubMed PubMed Central Google Scholar
• Van Wesenbeeck, L. et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72, 763–771 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537–543 (2001).
  Article CAS PubMed Google Scholar
• Leupin, O. et al. Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J. Bone Miner. Res. 22, 1957–1967 (2007).
  Article CAS PubMed Google Scholar
• Estrach, S., Ambler, C. A., Lo Celso, C., Hozumi, K. & Watt, F. M. Jagged 1 is a β-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development 133, 4427–4438 (2006).
  Article CAS PubMed Google Scholar
• Li, L. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nature Genet. 16, 243–251 (1997).
  Article CAS PubMed Google Scholar
• Engin, F. et al. Dimorphic effects of Notch signaling in bone homeostasis. Nature Med. 14, 299–305 (2008).
  Article CAS PubMed Google Scholar
• Xiong, J. et al. Matrix-embedded cells control osteoclast formation. Nature Med. 17, 1235–1241 (2011).
  Article CAS PubMed Google Scholar
• Fuller, K., Wong, B., Fox, S., Choi, Y. & Chambers, T. J. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188, 997–1001 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Simonet, W. S. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309–319 (1997).
  Article CAS PubMed Google Scholar
• Mizuno, A. et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247, 610–615 (1998).
  Article CAS PubMed Google Scholar
• Li, Y. et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109, 3839–3848 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Farooqi, I. S. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879–884 (1999).
  Article CAS PubMed Google Scholar
• Sobacchi, C. et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nature Genet. 39, 960–962 (2007).
  Article CAS PubMed Google Scholar
• Guerrini, M. M. et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am. J. Hum. Genet. 83, 64–76 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Whyte, M. P. et al. Osteoprotegerin deficiency and juvenile Paget's disease. N. Engl. J. Med. 347, 175–184 (2002).
  Article CAS PubMed Google Scholar
• Albagha, O. M. et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nature Genet. 42, 520–524 (2010).
  Article CAS PubMed Google Scholar
• Karsenty, G., Kronenberg, H. M. & Settembre, C. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25, 629–648 (2009).
  Article CAS PubMed Google Scholar
• Amizuka, N. et al. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev. Biol. 175, 166–176 (1996).
  Article CAS PubMed Google Scholar
• Smits, P., Dy, P., Mitra, S. & Lefebvre, V. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J. Cell Biol. 164, 747–758 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29 (2002).
  Article CAS PubMed Google Scholar
• Lee, B. et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genet. 16, 307–310 (1997).
  Article CAS PubMed Google Scholar
• Canalis, E. Update in new anabolic therapies for osteoporosis. J. Clin. Endocrinol. Metab. 95, 1496–1504 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lewiecki, E. M. Sclerostin: a novel target for intervention in the treatment of osteoporosis. Discovery Med. 12, 263–273 (2011).
  Google Scholar
• Gauthier, J. Y. et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 18, 923–928 (2008).
  Article CAS PubMed Google Scholar
• McClellan, J. & King, M. C. Genetic heterogeneity in human disease. Cell 141, 210–217 (2010).
  Article CAS PubMed Google Scholar
• Leslie, W. D. et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J. Bone Miner. Res. 25, 2350–2358 (2010).
  Article PubMed Google Scholar
• Pepe, M. S., Gu, J. W. & Morris, D. E. The potential of genes and other markers to inform about risk. Cancer Epidemiol. Biomarkers Prev. 19, 655–665 (2010).
  Article CAS Google Scholar
• Yang, J. et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nature Genet. 43, 519–525 (2011).
  Article CAS PubMed Google Scholar
• Ladouceur, M., Dastani, Z., Aulchenko, Y. S., Greenwood, C. M. & Richards, J. B. The empirical power of rare variant association methods: results from Sanger sequencing in 1,998 individuals. PLoS Genet. 8, e1002496 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ladouceur, M., Leslie, W. D., Dastani, Z., Goltzman, D. & Richards, J. B. An efficient paradigm for genetic epidemiology cohort creation. PLoS ONE 5, e14045 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Bell, J. T. & Spector, T. D. A twin approach to unraveling epigenetics. Trends Genet. 27, 116–125 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Talens, R. P. et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEB J. 24, 3135–3144 (2010).
  Article CAS PubMed Google Scholar
• Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54–60 (2011).
  Article CAS PubMed Google Scholar
• Kim, K. A. et al. R-spondin family members regulate the Wnt pathway by a common mechanism. Mol. Biol. Cell 19, 2588–2596 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Josse, R. G. Bone biology and the role of RANK/RANKL/OPG pathway. HealthPlexus [online], (2008).
  Google Scholar
• Mackie, E. J., Tatarczuch, L. & Mirams, M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J. Endocrinol. 211, 109–121 (2011).
  Article CAS PubMed Google Scholar
• Kung, A. W. et al. Association of JAG1 with bone mineral density and osteoporotic fractures: a genome-wide association study and follow-up replication studies. Am. J. Hum. Genet. 86, 229–239 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Koller, D. L. et al. Genome-wide association study of bone mineral density in premenopausal European-American women and replication in African-American women. J. Clin. Endocrinol. Metabolism 95, 1802–1809 (2010).
  Article CAS Google Scholar
• Ettinger, B. et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) investigators. JAMA 282, 637–645 (1999).
  Article CAS PubMed Google Scholar
• Neer, R. M. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434–1441 (2001).
  Article CAS PubMed Google Scholar
• Greenspan, S. L. et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann. Internal Med. 146, 326–339 (2007).
  Article Google Scholar
• Liberman, U. A. et al. Effect of oral alendronate on bone mineral. Density and the incidence of fractures in postmenopausal osteoporosis. New Engl. J. Med. 333, 1437–1444 (1995).
  Article CAS PubMed Google Scholar
• Rossouw, J. E. et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321–333 (2002).
  Article CAS PubMed Google Scholar